| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
44,309 |
38,102 |
$3.75M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,482 |
6,725 |
$1.17M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,096 |
3,610 |
$837K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
853 |
700 |
$333K |
| A0425 |
Ground mileage, per statute mile |
1,232 |
972 |
$255K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,124 |
2,013 |
$227K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
727 |
621 |
$208K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,278 |
1,199 |
$103K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,162 |
1,019 |
$94K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
519 |
477 |
$91K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
616 |
566 |
$65K |
| 36415 |
Collection of venous blood by venipuncture |
14,147 |
12,183 |
$40K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
351 |
343 |
$39K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
385 |
356 |
$38K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,022 |
945 |
$36K |
| 71045 |
Radiologic examination, chest; single view |
686 |
638 |
$29K |
| J3490 |
Unclassified drugs |
1,634 |
1,011 |
$24K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,677 |
1,481 |
$21K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
432 |
381 |
$18K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
126 |
124 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
420 |
389 |
$14K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
50 |
44 |
$14K |
| 80053 |
Comprehensive metabolic panel |
5,666 |
5,149 |
$12K |
| 0001A |
|
452 |
429 |
$12K |
| 0002A |
|
441 |
425 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,252 |
1,129 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
879 |
799 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,723 |
6,015 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
78 |
71 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
67 |
64 |
$7K |
| 90686 |
|
1,348 |
1,274 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
41 |
40 |
$5K |
| 80061 |
Lipid panel |
704 |
653 |
$5K |
| 0071A |
|
150 |
137 |
$5K |
| 0072A |
|
133 |
124 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
28 |
25 |
$4K |
| 20610 |
|
14 |
12 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
26 |
26 |
$3K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
26 |
24 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
235 |
219 |
$3K |
| 99173 |
|
491 |
463 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
171 |
159 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
90 |
78 |
$2K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
20 |
14 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,199 |
1,092 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
12 |
12 |
$2K |
| 87631 |
|
303 |
237 |
$2K |
| 0011A |
|
88 |
85 |
$2K |
| 0012A |
|
83 |
79 |
$2K |
| 86780 |
|
160 |
146 |
$2K |
| 90834 |
Psychotherapy, 45 minutes with patient |
12 |
12 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
28 |
28 |
$2K |
| 83605 |
|
614 |
523 |
$1K |
| 0004A |
|
38 |
35 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
37 |
37 |
$989.25 |
| 90670 |
|
129 |
119 |
$964.38 |
| 0124A |
|
25 |
24 |
$816.87 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
28 |
27 |
$711.67 |
| 81001 |
|
1,428 |
1,292 |
$710.85 |
| 86140 |
|
1,068 |
990 |
$687.90 |
| 91300 |
|
319 |
260 |
$661.87 |
| 84484 |
|
469 |
398 |
$638.97 |
| 90480 |
|
33 |
30 |
$435.81 |
| 96381 |
|
43 |
37 |
$412.98 |
| 86850 |
|
32 |
28 |
$410.16 |
| 90656 |
|
76 |
67 |
$406.91 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
227 |
166 |
$345.70 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
517 |
460 |
$297.02 |
| 84145 |
|
32 |
25 |
$293.86 |
| 0064A |
|
13 |
12 |
$287.42 |
| 99188 |
|
323 |
310 |
$278.86 |
| 0031A |
|
12 |
12 |
$259.38 |
| Q3014 |
Telehealth originating site facility fee |
27 |
27 |
$246.73 |
| 87040 |
|
75 |
55 |
$188.95 |
| 91307 |
|
86 |
61 |
$180.81 |
| 87634 |
|
16 |
15 |
$173.79 |
| 87210 |
|
67 |
61 |
$154.12 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
58 |
51 |
$149.86 |
| 87081 |
|
321 |
289 |
$141.24 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
30 |
28 |
$124.09 |
| 86901 |
|
17 |
15 |
$123.92 |
| 86900 |
|
17 |
15 |
$123.37 |
| 85018 |
|
41 |
41 |
$121.76 |
| 91301 |
|
47 |
43 |
$119.52 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
16 |
16 |
$102.25 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
59 |
54 |
$93.49 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
133 |
115 |
$93.48 |
| 81025 |
|
49 |
47 |
$87.60 |
| 85027 |
|
12 |
12 |
$74.95 |
| 87340 |
|
16 |
14 |
$65.96 |
| 82077 |
|
85 |
79 |
$57.61 |
| 86803 |
|
16 |
14 |
$57.32 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
96 |
88 |
$48.60 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
12 |
$30.17 |
| 85610 |
|
12 |
12 |
$21.85 |
| 90685 |
|
33 |
30 |
$20.52 |
| 83690 |
|
76 |
70 |
$11.36 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
107 |
26 |
$9.09 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
28 |
26 |
$7.48 |
| 81003 |
|
39 |
39 |
$2.31 |
| A9270 |
Non-covered item or service |
129 |
89 |
$0.00 |
| 85379 |
|
12 |
12 |
$0.00 |
| 90744 |
|
15 |
15 |
$0.00 |
| 90698 |
|
72 |
71 |
$0.00 |
| 90381 |
|
16 |
14 |
$0.00 |
| 90680 |
|
30 |
28 |
$0.00 |
| 90697 |
|
14 |
13 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
470 |
381 |
$0.00 |
| 80305 |
|
50 |
46 |
$0.00 |